NCT04908306Completed
IMAGE-HF: Project IIa Canadian CArdiomyopathy Registry for Device Therapy
IMAGE-HF: Project IIa - Canadian CArdiomyopathy Registry for Device Therapy (CanCARD-MR)
Source: ClinicalTrials.gov · Last updated 13 May 2026
Brief summary (registry, in English)
Delayed enhanced MRI in patients (of either ischemic or non-ischemic cause) being referred for primary prevention ICD
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 502 (actual)
- First submitted
- 26 May 2021
- Start date
- 11 Oct 2011
- Primary completion date
- 12 Jul 2024
- Lead sponsor
- Ottawa Heart Institute Research Corporation
- Diseases
- Heart failure
- NCT number
- NCT04908306
What you commit to
- Study type: Observational
- Participants enrolled: 502
- From 11 Oct 2011 to the primary completion date, 12 Jul 2024
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Recent myocardial infarction or revascularization procedure within the past 3 months.
Lab values
- GFR (glomerular filtration rate) ≤ 30 ml. / min/ m2.
Other
- Known contra-indications to MRI.
Who the study is looking for
- .Any patient accepted for primary prevention ICD (+/-) CRT)
Sex: All
This page is information, not medical advice. Discuss any trial with your doctor.